All stock lists
Microvast Holdings, Inc. (NASDAQ:MVST)
US · Delayed Price · Currency is USD
Industrials · Electrical Equipment & Parts
0.22-0.40 (-64.34%)
Market cap
$73.4M
Insider Score
Health Score
Analyst consensus
Listed since
Mar 27, 2019
Website
Insider Score
––Not scored
MVST Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Distressed
From MVST’s reported statements · Q3 2026 (trailing 12 months)
Profitability6 / 20
Loses money on what it sells.
- Revenue
- $290.1M
- Net income
- -$24.0M
- Net margin
- -8.3%
Leverage0 / 20
Heavily indebted for what it earns.
- Total debt
- $167.7M
- Cash
- $84.8M
- Net debt / EBITDA
- 17.37x
Liquidity7 / 20
Owes more within a year than it holds to pay it.
- Current assets
- $352.7M
- Current liabilities
- $355.8M
- Current ratio
- 0.99
Cash generation0 / 20
Consumes cash and must keep raising it.
- Operating cash flow
- -$68.8M
- Free cash flow
- -$86.0M
- FCF margin
- -29.6%
Dilution & runway5 / 20
Heavy dilution — shareholders are paying for the business.
- Shares outstanding
- 384.5M
- Share growth (1y)
- 18.8%
- Cash runway
- 15 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
MVST Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 |
| Revenue | 45.80 M | 87.26 M | 60.61 M | 96.40 M | 123.29 M | 91.34 M |
| Revenue Growth (YoY) | -62.85 % | -4.46 % | -47.97 % | -14.98 % | 21.60 % | 9.16 % |
| Cost of Revenue | 43.44 M | 61.48 M | 41.46 M | 95.44 M | 76.88 M | 59.62 M |
| Gross Profit | 2.37 M | 25.78 M | 19.16 M | 959.00 K | 46.41 M | 31.72 M |
| SG&A Expense | 19.84 M | 18.63 M | 18.28 M | 29.68 M | 25.67 M | 7.42 M |
| R&D Expense | 8.36 M | 8.86 M | 8.81 M | 10.38 M | 7.76 M | 7.72 M |
| Operating Expenses | 69.04 M | 27.50 M | 27.09 M | 39.37 M | 33.42 M | 15.51 M |
| Operating Income | -66.68 M | -1.72 M | -7.93 M | -38.41 M | 12.99 M | 16.21 M |
| Pretax Income | -71.37 M | -11.99 M | 48.21 M | 10.26 M | -750.00 K | -105.84 M |
| Tax Provision | 5.43 M | 0.00 | 0.00 | -6.28 M | 739.00 K | 220.00 K |
| Net Income | -76.80 M | -11.99 M | 48.21 M | 16.54 M | -1.49 M | -106.06 M |
| EPS (Basic) | -0.20 | -0.03 | 0.15 | 0.05 | -0.00 | -0.33 |
| EPS (Diluted) | -0.20 | -0.03 | -0.04 | 0.05 | -0.00 | -0.33 |
| Shares Outstanding | 384.54 M | 348.95 M | 332.36 M | 327.93 M | 323.76 M | 323.64 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.